Johnson & Johnson buy Maxi_Scalibusa
Summary
This prediction ended on 29.12.22 with a price of €165.62. The BUY prediction by Maxi_Scalibusa finished with a performance of 10.44%. A total of €4.23 was paid as dividends for this prediction. Maxi_Scalibusa has 50% into this predictionJohnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.
Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Johnson & Johnson | 0.956% | 0.956% | -1.421% |
iShares Core DAX® | -1.471% | 1.895% | 25.178% |
iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% |
iShares Nikkei 225® | -2.115% | 2.450% | 20.561% |
iShares S&P 500 | 0.394% | 3.118% | 29.456% |
According to Maxi_Scalibusa what are the pros and cons of Johnson & Johnson for the foreseeable future?
Pros
Cons
Comments by Maxi_Scalibusa for this prediction
In the thread Johnson & Johnson diskutieren
In the thread Trading Johnson & Johnson
Stopped prediction by Maxi_Scalibusa for Johnson & Johnson
Johnson & Johnson
17.07.18
04.11.21
05.11.21